Thank you all, especially to our customers, distributors, agents and guests for visiting our booth at the EFI Annual Meeting 2019 in Lisbon, Portugal! Special thanks to all our guest speakers – Prof. Mehdi Tafti, Dr. Mohamed Jahromi, Dr. Dominique Masson, Dr. Valia Bravo-Egana, Dr. Mette Christiansen and Dr. Monica Dutescu – for taking the time to come and be part of our Lunchtime Symposium and User Group Meeting, and to all organizers for this amazing conference in Lisbon.
Advances in Disease Associations Using NGS-based HLA Typing
More than 120 professionals attended our Lunchtime Symposium presentation which focused on the science of HLA and disease associations with Professor Mehdi Tafti from University of Lausanne in Switzerland speaking about Narcolepsy and Dr. Mohamed Jahromi from Dasman Diabetes Institute in Kuwait who presented on how NGS-based HLA typing has aided his research on Type 1 Diabetes.
User Group Meeting Presentations
The interactive User Group Meeting on Wednesday, May 8 was a forum where participants could learn about Omixon’s products, interact with current users and network with NGS and HLA experts. Guest Speaker presentations by Monica Dutescu (National HLA Laboratory, Bucharest), Dominique Masson (EFS Rhone-Alp, Grenoble), Valia Bravo-Egana (Medical College of Georgia), Mette Christiansen (Aarhus University Hospital) are also included.
Scientific Posters Presented at EFI 2019
- Automating Holotype HLA on Eppendorf’s Epmotion Liquid Handler and Validating it for Routine HLA Genotyping
- Evaluation of Omixon Holotype HLA on the iSeq 100 Instrument
- High Throughput HLA Typing Using NGS with Semi-automated Workflow
- Interfacing a Next generation Sequencing Bioinformatic Pipeline with a Laboratory Information Management System for Use with High Resolution Typing Results and Reporting
- Donor Selecton for Solid Organ Transplantation Guided by NGS High Resolution HLA Typing in Combination with PIRCHE
- NGS High Resolution Typing in Combination with PIRCHE as a Tool to Select a Permissible HSCT Donor
- Novel HLA Alleles Based on Polymorphism Outside the Key Exons as a Result of Full Length NGS: What Now?